NewAmsterdam Pharma (NAMS) Net Income (2023 - 2026)
NewAmsterdam Pharma (NAMS) reported Net Income of -$64.14 million for Q2 2026, compared with -$17.36 million a year earlier.
NewAmsterdam Pharma (NAMS) Net Income (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, NewAmsterdam Pharma's Net Income came in at -$259.5 million; for FY2025, it came in at -$203.82 million.
- By year, Net Income came in at -$241.6 million in FY2024, -$176.94 million in FY2023, -$82.26 million in FY2022 and -$33.84 million in FY2021.
- Five-year quarterly Net Income spans a low of -$93.77 million in Q1 2024 and a high of -$16.65 million in Q3 2024.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$48.44 million (Q1 2026), -$74.92 million (Q4 2025) and -$72.01 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | NewAmsterdam Pharma | 2.86 Bn | 2.86 Bn | - | -64.14 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -64.14 Mn |
| Mar 31, 2026 | -48.44 Mn |
| Dec 31, 2025 | -74.92 Mn |
| Sep 30, 2025 | -72.01 Mn |
| Jun 30, 2025 | -17.36 Mn |
| Mar 31, 2025 | -39.53 Mn |
| Dec 31, 2024 | -92.18 Mn |
| Sep 30, 2024 | -16.65 Mn |
| Jun 30, 2024 | -39.01 Mn |
| Mar 31, 2024 | -93.77 Mn |
| Dec 31, 2023 | -49.47 Mn |
| Sep 30, 2023 | -47.13 Mn |
| Jun 30, 2023 | -38.29 Mn |
| Mar 31, 2023 | -42.02 Mn |
NewAmsterdam Pharma Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=NAMS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();